PWAM
TBPH icon

Park West Asset Management’s Theravance Biopharma TBPH Stock Holding History

Park West Asset Management’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-181,507
Closed -$3.4M – 60
2025
Q4 		$3.4M Sell
181,507
-1,102,574
-86% -$18.3M 0.28% 45
2025
Q3 		$18.7M Sell
1,284,081
-515,000
-29% -$6.51M 1.58% 28
2025
Q2 		$19.8M Sell
1,799,081
-5,163
-0.3% -$50.2K 1.5% 31
2025
Q1 		$16.1M Buy
1,804,244
+11,256
+0.6% +$105K 1.3% 31
2024
Q4 		$16.9M Sell
1,792,988
-70,000
-4% -$637K 1.36% 31
2024
Q3 		$15M Buy
1,862,988
+162,988
+10% +$1.41M 1.07% 32
2024
Q2 		$14.4M Buy
1,700,000
+542,837
+47% +$4.9M 1.06% 35
2024
Q1 		$10.4M Buy
1,157,163
+257,163
+29% +$2.38M 0.74% 29
2023
Q4 		$10.1M Sell
900,000
-1,083,251
-55% -$10.9M 0.99% 28
2023
Q3 		$17.1M Buy
1,983,251
+262,500
+15% +$2.53M 1.57% 18
2023
Q2 		$17.8M Sell
1,720,751
-179,452
-9% -$1.98M 1.56% 18
2023
Q1 		$20.6M Sell
1,900,203
-20,121
-1% -$213K 1.84% 16
2022
Q4 		$21.5M Buy
1,920,324
+970
+0.1% +$10.2K 2.11% 15
2022
Q3 		$19.5M Sell
1,919,354
-1,253,900
-40% -$11.7M 1.38% 19
2022
Q2 		$28.8M Buy
3,173,254
+2,833,254
+833% +$26.1M 1.63% 19
2022
Q1 		$3.25M Buy
+340,000
New +$3.33M 0.11% 64

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Park West Asset Management's TBPH Position: Q1 2026 in Review

Park West Asset Management sold out of Theravance Biopharma (TBPH) in Q1 2026, closing a stake of 181,507 shares — an estimated $3.4M sold.

Park West Asset Management first reported a position in TBPH in Q1 2022 and held it in 16 quarters. The position peaked at $28.8M in Q2 2022. 174 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.

  • Park West Asset Management reported no remaining Theravance Biopharma position as of Q1 2026 after selling out during the quarter.
  • Park West Asset Management sold 181,507 Theravance Biopharma shares in Q1 2026, an estimated $3.4M.
  • Park West Asset Management first reported a position in Theravance Biopharma in Q1 2022 and held it in 16 quarters.
  • Park West Asset Management's Theravance Biopharma position peaked at $28.8M in Q2 2022.
  • 174 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.

Based on Park West Asset Management's 13F filing for Q1 2026, filed 15 May 2026.